The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
In a span of 4 days, Congress passed legislation to fund the government through March…
Before the close of 2017, all physicians must take action to avoid the 4 percent…
The Centers for Medicare and Medicaid Services (CMS) released a proposed rule outlining the requirements…
08/08/25: Scientific Abstract Submission Deadline
Learn more
12/01/25: Research Grant Cycle
Learn more
06/01/26: Fellow Exam Application Deadline
Learn more
06/01/26: Research Grant Cycle
Learn more
This fall, November 14-16, take your learning to the next level—while soaking up the coastal beauty of Oceanside, CA, by attending the 2025 AAOA Annual Meeting. Whether you’re a seasoned ENT allergy provider or building a new service line, the 2025 AAOA Annual Meeting brings you cutting-edge education, actionable practice tips, and networking opportunities. Register Today
Focusing on surgical and medical management of airway disease in ENT, the Explorers Course 2026 will focus on the "sinus” headache, ocular manifestations of allergies and treatments beyond antihistamine eye drops, food allergy, microbiome and allergies/sinusitis, changing environment, and more. Learn about the Explorers Course 2026 here.
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2026:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access December 22-March 23, 2026
January 22-24, 2026 - Live
Fairmont Sonoma Mission Inn & Spa,
Sonoma, CA
Learn More and Register
2026 AAOA Basic Course in Allergy & Immunology – Hybrid
90-days Access June 9– Sep 14, 2026
July 9-11, 2026 – Live
The Diplomat, Hollywood, Florida
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available October 1 - December 31, 2025
American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices…
After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of…
You are encouraged to remain vigilant when any symptoms of URI emerge, especially as COVID…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
The lists below of the most cited and most accessed (downloaded) articles from IFAR (International Forum of Allergy and Rhinology) during 2017-18. Top-10 Cited IFAR Articles Published 2017-2018: Evidence of microbiota dysbiosis in chronic rhinosinusitisVolume 7, Issue 3First Author: Michael Hoggard BSc(hons)Senior Author:…
The history of modern allergy treatment dates back to the early decades of the twentieth century with the demonstration of decreased response to grass pollens following conjunctival challenge done by Noon and Freeman. These techniques were subsequently modified that led…
The Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversable obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB)…
...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date education and information on the practice of Allergy. I attended my first AAOA Course 20 years ago and have witnessed significant changes in how we diagnose and treat allergic disease. Older diagnostic and…
I want to urge you to consider membership in the AMA because your membership in AMA gives us a voice. The American Medical Association is one organization that the AAOA works through to advocate for issues related to the AAOA. …
Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released a proposed update to Chapter 797 in 2015, AAOA has been working with other concerned organizations including the American Academy of Allergy, Asthma & Immunology,…
On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee Schedule (PFS) detailing policies related to Medicare physician payment and the Quality Payment Program (QPP). A brief summary of key provisions for AAOA members follows:…
You have allergy symptoms, and want to find something to treat your symptoms without having to go to a doctor. The allergy aisle in the pharmacy or big box store is overwhelming. What do all these drugs do? Let's break…
The Food and Drug Administration (FDA) states, in a revised draft guidance released this week, that it does not intend to enforce the “insanitary conditions” provision of the Food, Drug and Cosmetic Act against physicians that compound or mix in their…
The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its sponsoring organization, the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American Academy of Otolaryngic Allergy (AAOA) submitted comments on the proposed changes…